Namenda Buyers' Experts Should Stay, Judge Says
A New York magistrate judge on Thursday recommended allowing the testimony of two experts in an antitrust suit alleging Forest Laboratories LLC blocked generic alternatives to its Namenda Alzheimer's treatment....To view the full article, register now.
Already a subscriber? Click here to view full article